iShares Biotechnology ETF
414 hedge funds and large institutions have $6.44B invested in iShares Biotechnology ETF in 2015 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 145 increasing their positions, 140 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
31% less funds holding in top 10
Funds holding in top 10: 42 → 29 (-13)
41% less call options, than puts
Call options by funds: $866M | Put options by funds: $1.47B
Holders
414
Holding in Top 10
29
Calls
$866M
Puts
$1.47B
Top Buyers
| 1 | +$318M | |
| 2 | +$251M | |
| 3 | +$229M | |
| 4 |
Goldman Sachs
New York
|
+$151M |
| 5 |
Citigroup
New York
|
+$74.6M |
Top Sellers
| 1 | -$124M | |
| 2 | -$85.9M | |
| 3 | -$31.4M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$18.8M |
| 5 |
ACM
Arlington Capital Management
Arlington Heights,
Illinois
|
-$17.7M |